195 |
Chen L.-T.; Vogel A.; Hsu C.; Chen M.-H.; Fang W.; Pangarsa E.A.; Sharma A.; Ikeda M.; Park J.O.; Tan C.K.; Regala E.; Tai D.; Tanasanvimon S.; Charoentum C.; Chee C.E.; Lui A.; Sow J.; Oh D.-Y.; Ueno M.; Ramaswamy A.; Jeo W.S.; Zhou J.; Curigliano G.; Yoshino T.; Bai L.-Y.; Pentheroudakis G.; Chiang N.-J.; Cervantes A.; Chen J.-S.; Ducreux M. |
Chen, L.-T. (7409440415); Vogel, A. (7102618692); Hsu, C. (15756011800); Chen, M.-H. (35186849800); Fang, W. (16836058600); Pangarsa, E.A. (57204907532); Sharma, A. (57223648792); Ikeda, M. (35399280200); Park, J.O. (57977780300); Tan, C.K. (58288943100); Regala, E. (57196113996); Tai, D. (36180376300); Tanasanvimon, S. (23089332900); Charoentum, C. (6507550908); Chee, C.E. (15838788600); Lui, A. (58911235000); Sow, J. (59250312400); Oh, D.-Y. (8836932000); Ueno, M. (57197706804); Ramaswamy, A. |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer |
ESMO Open |
0 |
Kaohsiung Medical University Hospital, Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover, Hannover, Germany; Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada; Department of Oncology, National Taiwan University Hospital, Taipei; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Haematology Medical Oncology Division, Department of Oncology, Faculty of Medicine, Diponegoro University/Dr. Kariadi Hospital, Semarang, Indonesia; Department of Medical Oncology, Max Institute of Cancer Care, Max Super Specialty Hospital, Saket, New Delhi, India; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Oncology and Nuclear Medicine, Thomson Hospital Kota Damansara, Selangor, Petaling Jaya, Malaysia; Clinical Division Building, University of Santo Tomas Hospital, Sampaloc, Manila, Philippines; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore; Department of Internal Medicine, Metro Davao Medical and Research Center, Davao City, Philippines; Section of Medical Oncology, Department of Internal Medicine, Southern Philippines Medical Center, The Philippines, Davao City, Philippines; Department of Oncology, Curie Oncology Kuala Lumpur, Kuala Lumpur, Malaysia; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, India; Division of Digestive Surgery, Department of General Surgery, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China; Istituto Europeo di Oncologia, Milano, IRCCS, Milano; Department of Oncology and Haematology, University of Milano, Milano, Italy; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan; ESMO, Lugano, Switzerland; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC. Instituto de Salud Carlos III, Madrid, Spain; Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan; INSERM U1279, Université Paris-Saclay, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, Villejuif, France |
Q1 |
|
|